<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>53</volume><submitter>Fujita M</submitter><funding>Japan Agency for Medical Research and Development</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The tumor microenvironment can be classified into immunologically active "inflamed" tumors and inactive "non-inflamed" tumors based on the infiltration of cytotoxic immune cells. Previous studies on liver cancer have reported a superior prognosis for inflamed tumors compared to non-inflamed tumors. However, liver cancer is highly heterogeneous immunologically and genetically, and a finer classification of the liver cancer microenvironment may improve our understanding of its immunological diversity and response to immune therapy.&lt;h4>Methods&lt;/h4>We characterized the immune gene signatures of 234 primary liver cancers, mainly virus-related, from a Japanese population using RNA-Seq of tumors and matched non-tumorous hepatitis livers. We then compared them with the somatic a</pubmed_abstract><journal>EBioMedicine</journal><pagination>102659</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7048625</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations.</pubmed_title><pmcid>PMC7048625</pmcid><pubmed_authors>Imoto S</pubmed_authors><pubmed_authors>Fujita M</pubmed_authors><pubmed_authors>Tanaka H</pubmed_authors><pubmed_authors>Hayami S</pubmed_authors><pubmed_authors>Shimada S</pubmed_authors><pubmed_authors>Yamaue H</pubmed_authors><pubmed_authors>Hasegawa T</pubmed_authors><pubmed_authors>Chayama K</pubmed_authors><pubmed_authors>Arihiro K</pubmed_authors><pubmed_authors>Hayashi S</pubmed_authors><pubmed_authors>Nakano K</pubmed_authors><pubmed_authors>Aikata H</pubmed_authors><pubmed_authors>Nakagawa H</pubmed_authors><pubmed_authors>Ueno M</pubmed_authors><pubmed_authors>Yamaguchi R</pubmed_authors><pubmed_authors>Tanaka S</pubmed_authors><pubmed_authors>Fujimoto A</pubmed_authors><pubmed_authors>Miyano S</pubmed_authors><pubmed_authors>Maejima K</pubmed_authors><pubmed_authors>Ono A</pubmed_authors><pubmed_authors>Kakimi K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations.</name><description>&lt;h4>Background&lt;/h4>The tumor microenvironment can be classified into immunologically active "inflamed" tumors and inactive "non-inflamed" tumors based on the infiltration of cytotoxic immune cells. Previous studies on liver cancer have reported a superior prognosis for inflamed tumors compared to non-inflamed tumors. However, liver cancer is highly heterogeneous immunologically and genetically, and a finer classification of the liver cancer microenvironment may improve our understanding of its immunological diversity and response to immune therapy.&lt;h4>Methods&lt;/h4>We characterized the immune gene signatures of 234 primary liver cancers, mainly virus-related, from a Japanese population using RNA-Seq of tumors and matched non-tumorous hepatitis livers. We then compared them with the somatic a</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Mar</publication><modification>2026-05-03T11:24:41.877Z</modification><creation>2020-05-22T12:05:22Z</creation></dates><accession>S-EPMC7048625</accession><cross_references><pubmed>32113157</pubmed><doi>10.1016/j.ebiom.2020.102659</doi></cross_references></HashMap>